{
    "Trade/Device Name(s)": [
        "Access Ferritin"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K234052",
    "Predicate Device Reference 510(k) Number(s)": [
        "K926221",
        "K052082"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JMG"
    ],
    "Summary Letter Date": "March 20, 2024",
    "Summary Letter Received Date": "December 21, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5340"
    ],
    "Regulation Name(s)": [
        "Ferritin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Ferritin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DxI 9000 Access Immunoassay Analyzer",
        "Access Immunoassay Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Sandwich immunoenzymatic assay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Buffer",
        "Substrate"
    ],
    "Document Summary": "FDA 510(k) summary for Access Ferritin chemiluminescent immunoassay to quantify ferritin in serum and plasma on the DxI 9000 Access Immunoassay Analyzer",
    "Indications for Use Summary": "Quantitative determination of ferritin levels in human serum and plasma (heparin) as an aid in diagnosis of iron deficiency or iron overload",
    "fda_folder": "Immunology"
}